According to the current analysis of Reports and Data, The global Atherectomy market was valued at USD 1.30 billion in 2020 and is expected to reach USD 2.01 billion by year 2028, at a CAGR of 6.4%.
According to the current analysis of Reports and Data, The global Atherectomy market was valued at USD 1.30 billion in 2020 and is expected to reach USD 2.01 billion by year 2028, at a CAGR of 6.4%. Atherectomy is a procedure to remove plaque from an artery. Removing plaque makes the artery wider so the blood can flow more freely to the muscles. This procedure is used to treat peripheral artery disease and coronary artery disease. The procedure is sometimes performed on patients with very hard plaque or on patients who have already had an angioplasty and stents but still have plaque blocking the blood flow. The procedure is specifically designed to treat narrowing in arteries caused by peripheral artery diseases. It is a frequently opted alternative to Angioplasty. The surgery is not too costly either making it an apt alternative to angioplasty. The surgery is quicker than the traditional open surgery and thus is preferred by most. In addition, it is a faster and a simpler procedure to perform and therefore is advised by many surgeons.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/1683
Further key findings from the report suggest
-
- Minimal invasiveness has been attracting the attention of many in the recent times. Since Atherectomy is one of the major types of minimal intrusive treatments, there has been a spur of growth in the demand for this procedure. Increasing cases of peripheral artery diseases and coronary artery diseases, has triggered research and development initiatives to develop several innovative solutions for the treatment purposes, which lays a foundation for future growth.
- A lot of research and development is being carrying out continuously for launching novel, improved devices in the market has been encouraging demand for the Atherectomy market.
- The biggest factor attracting the market is its minimal invasiveness. With the rising preference of the people to opt for minimal invasive surgeries has been the key factor propelling the market.
- Excisional or Directional Atherectomy dominates the market with the largest market share of around 42.4% and is also expected to register the highest CAGR of 7.1% owing to its technologically advanced nature. This is followed by Rotational Atherectomy with a market share of 25.4% and a CAGR of 6.4%
- The Peripheral Artery Disease dominates the market for treatment due to the rise in the cases of PAD. This is followed by Coronary Artery diseases.
- Asia Pacific is the fastest growing sector with a CAGR of 7.1%. The continuous development in the emerging countries has led to better medical infrastructures. The governments of various emerging economies have been providing medical aids to the people to promote minimally invasive surgeries. This has further increased the demand for Atherectomy in such regions.
- North America dominates the market with the largest market share due to the continuous technological advancements and research and development for developing better and more efficient devices for the procedure. North America is expected to register a CAGR of 6.9%.
- Europe follows North America with the second largest market share. The rising cardiovascular problems among the people and the preference of the people for minimally invasive procedures have increased the demand for Atherectomy in this region. The region is expected to continue its growth at a CAGR of 6.3%.
The ongoing pandemic is significantly changing the dynamics of the pharma and healthcare sector. Various countries are facing challenges such as shortage of medicines, vaccines, healthcare devices in hospitals. This is expected to open lucrative growth opportunities for market players in the coming years.
Competitive Landscape:
The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, merger and acquisitions, collaborations, and joint ventures to gain robust footing in the market.
Top Companies Profiled in the Report:
Phillips Healthcare, Bayer AG, BARD Peripheral Vascular Inc., Boston Scientific, Medtronics, Cardiovascular Systems Inc. and Avinger Inc.
To know more about the report, visit @ https://www.reportsanddata.com/report-detail/atherectomy-market
Atherectomy Market Segmentation:
Type (Revenue, USD Million; 2018–2028)
- Excisional
- Transluminal
- Laser
- Rotational
- Orbital
- Other
Application (Revenue, USD Million; 2018–2028)
- Peripheral Artery Diseases
- Coronary Artery Disease
- Neurovascular Disease
Regional Outlook:
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Latin America (Brazil, Rest of LATAM)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/1683
This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.
Explore Latest Trending Research Reports By Reports and Data:
Delirium Market Size, Share, Trends, Distribution channel Outlook (Offline, Online ), End-Use Outlook (Hospitals, Speciality clinics), Disease Type Outlook (Hyperactive delirium, Hypoactive delirium, Mixed delirium), By Route of administration Outlook, By Treatment Outlook, By Dosage form Outlook and By Region Forecast to 2030 Download PDF Brochure
Panic Disorder Market Size, Share, Trends, End-Use Outlook (Hospital Pharmacies, Retailer pharmacies, Online Pharmacy stores) Distribution Channel Outlook (Online, Offline), Route of administration Outlook, Treatment Outlook, Dosage form Outlook and By Region Forecast to 2030 Download PDF Brochure
Aplastic Anemia Market Size, Share, Trends, Disease Type Outlook (Acquired Aplastic anemia, Inherited Aplastic Anemia), Disease Cause Outlook (Viral Infectious, Auto-immune Reaction, Medications, Chemical exposure, Radiation and Chemotherapy, Others), By Distribution Channel Outlook, Route of Administration Outlook, Treatment outlook, Drug Type Outlook and By Region Forecast to 2030 Download PDF Brochure
Traumatic Brain Injury Treatment Market Size, Share, Trends, Product Type Outlook (Tablets, Capsules, Injectable, Others), Disease Type Outlook (Mild, Moderate, Severe), By Route of Administration, By Distribution Channel By End Users and By Region Forecast to 2030 Download PDF Brochure
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read the innovative blog at https://www.reportsanddata.com/blogs
Check out our upcoming research report at https://www.reportsanddata.com/upcoming-reports
Atherectomy is a procedure to remove plaque from an artery. Removing plaque makes the artery wider so the blood can flow more freely to the muscles. This procedure is used to treat peripheral artery disease and coronary artery disease. The procedure is sometimes performed on patients with very hard plaque or on patients who have already had an angioplasty and stents but still have plaque blocking the blood flow. The procedure is specifically designed to treat narrowing in arteries caused by peripheral artery diseases. It is a frequently opted alternative to Angioplasty. The surgery is not too costly either making it an apt alternative to angioplasty. The surgery is quicker than the traditional open surgery and thus is preferred by most. In addition, it is a faster and a simpler procedure to perform and therefore is advised by many surgeons.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/1683
Further key findings from the report suggest
-
- Minimal invasiveness has been attracting the attention of many in the recent times. Since Atherectomy is one of the major types of minimal intrusive treatments, there has been a spur of growth in the demand for this procedure. Increasing cases of peripheral artery diseases and coronary artery diseases, has triggered research and development initiatives to develop several innovative solutions for the treatment purposes, which lays a foundation for future growth.
- A lot of research and development is being carrying out continuously for launching novel, improved devices in the market has been encouraging demand for the Atherectomy market.
- The biggest factor attracting the market is its minimal invasiveness. With the rising preference of the people to opt for minimal invasive surgeries has been the key factor propelling the market.
- Excisional or Directional Atherectomy dominates the market with the largest market share of around 42.4% and is also expected to register the highest CAGR of 7.1% owing to its technologically advanced nature. This is followed by Rotational Atherectomy with a market share of 25.4% and a CAGR of 6.4%
- The Peripheral Artery Disease dominates the market for treatment due to the rise in the cases of PAD. This is followed by Coronary Artery diseases.
- Asia Pacific is the fastest growing sector with a CAGR of 7.1%. The continuous development in the emerging countries has led to better medical infrastructures. The governments of various emerging economies have been providing medical aids to the people to promote minimally invasive surgeries. This has further increased the demand for Atherectomy in such regions.
- North America dominates the market with the largest market share due to the continuous technological advancements and research and development for developing better and more efficient devices for the procedure. North America is expected to register a CAGR of 6.9%.
- Europe follows North America with the second largest market share. The rising cardiovascular problems among the people and the preference of the people for minimally invasive procedures have increased the demand for Atherectomy in this region. The region is expected to continue its growth at a CAGR of 6.3%.
The ongoing pandemic is significantly changing the dynamics of the pharma and healthcare sector. Various countries are facing challenges such as shortage of medicines, vaccines, healthcare devices in hospitals. This is expected to open lucrative growth opportunities for market players in the coming years.
Competitive Landscape:
The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, merger and acquisitions, collaborations, and joint ventures to gain robust footing in the market.
Top Companies Profiled in the Report:
Phillips Healthcare, Bayer AG, BARD Peripheral Vascular Inc., Boston Scientific, Medtronics, Cardiovascular Systems Inc. and Avinger Inc.
To know more about the report, visit @ https://www.reportsanddata.com/report-detail/atherectomy-market
Atherectomy Market Segmentation:
Type (Revenue, USD Million; 2018–2028)
- Excisional
- Transluminal
- Laser
- Rotational
- Orbital
- Other
Application (Revenue, USD Million; 2018–2028)
- Peripheral Artery Diseases
- Coronary Artery Disease
- Neurovascular Disease
Regional Outlook:
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Latin America (Brazil, Rest of LATAM)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/1683
This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.
Explore Latest Trending Research Reports By Reports and Data:
Delirium Market Size, Share, Trends, Distribution channel Outlook (Offline, Online ), End-Use Outlook (Hospitals, Speciality clinics), Disease Type Outlook (Hyperactive delirium, Hypoactive delirium, Mixed delirium), By Route of administration Outlook, By Treatment Outlook, By Dosage form Outlook and By Region Forecast to 2030 Download PDF Brochure
Panic Disorder Market Size, Share, Trends, End-Use Outlook (Hospital Pharmacies, Retailer pharmacies, Online Pharmacy stores) Distribution Channel Outlook (Online, Offline), Route of administration Outlook, Treatment Outlook, Dosage form Outlook and By Region Forecast to 2030 Download PDF Brochure
Aplastic Anemia Market Size, Share, Trends, Disease Type Outlook (Acquired Aplastic anemia, Inherited Aplastic Anemia), Disease Cause Outlook (Viral Infectious, Auto-immune Reaction, Medications, Chemical exposure, Radiation and Chemotherapy, Others), By Distribution Channel Outlook, Route of Administration Outlook, Treatment outlook, Drug Type Outlook and By Region Forecast to 2030 Download PDF Brochure
Traumatic Brain Injury Treatment Market Size, Share, Trends, Product Type Outlook (Tablets, Capsules, Injectable, Others), Disease Type Outlook (Mild, Moderate, Severe), By Route of Administration, By Distribution Channel By End Users and By Region Forecast to 2030 Download PDF Brochure
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read the innovative blog at https://www.reportsanddata.com/blogs
Check out our upcoming research report at https://www.reportsanddata.com/upcoming-reports